​

​

Welcome to the Computational Clinical Oncology Group at Gustave Roussy.

​

Our group is dedicated to computational cancer research and its applications to precision oncology. Using cancer genomics and statistical learning, we analyze patients samples from retrospective and prospective studies  with a focus on early cancer detection and clinical trials of innovative therapies. We seek to unravel the molecular underpinning of tumor evolution, genotype-phenotype relationships, and the determinants of response and resistance to treatments. We develop clinical decision tools that support diagnostic classification and patient risk stratification.